ClassID:

94701

C07D265/30 - CPC Classification

Classification description:

Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms 1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings

Sub-classes:
Recent Application in this class:
#1
20260132115
2026-05-14

SUBSTITUTED 3-FLUOROBENZENEPROPANOATE COMPOUND AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF

#2
20260116845
2026-04-30

LIPIDS AND COMPOSITIONS THEREOF

#3
20260108482
2026-04-23

MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS

#4
20260103454
2026-04-16

MODULATORS OF HEMOGLOBIN

#5
20260078098
2026-03-19

PROCESS OF MAKING DERIVATIVES OF SUBSTITUTED MORPHOLINES

#6
20260062395
2026-03-05

PROCESS AND INTERMEDIATES FOR THE PREPARATION OF VILOXAZINE AND OTHER 2-SUBSTITUTED MORPHOLINE DERIVATIVES

#7
20260055101
2026-02-26

PREPARATION OF P2X3 ANTAGONIST

#8
20260049054
2026-02-19

NOVEL POTASSIUM CHANNEL INHIBITORS

#9
20260008759
2026-01-08

METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOF

#10
20260001838
2026-01-01

NANOMATERIALS

#11
20250388560
2025-12-25

AROMATIC COMPOUND AND USE THEREOF

#12
20250388536
2025-12-25

3-ALKYNYL CARBOXAMIDES AS AEP MODULATORS

#13
20250388531
2025-12-25

SUBSTITUTED TETRACYCLINE COMPOUNDS

#14
20250382270
2025-12-18

3-DIARYLMETHYLENES AND USES THEREOF

#15
20250376432
2025-12-11

PROCESS FOR PREPARING MODULATORS OF EUKARYOTIC INITIATION FACTOR 2B

#16
20250368634
2025-12-04

PHENYL AMIDE COMPOUNDS AND METHODS OF USE

#17
20250361205
2025-11-27

ENZYME-CLEAVABLE METHADONE PRODRUGS AND METHODS OF USE THEREOF

#18
20250340514
2025-11-06

3-DIARYLMETHYLENES AND USES THEREOF

#19
20250333387
2025-10-30

CRYSTALLINE CHLORO-N-(4-(MORPHOLINOMETHYL)PHENYL)BENZAMIDE AND CRYSTALLINE HYDROCHLORIDE SALT

#20
20250326713
2025-10-23

INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

#21
20250313535
2025-10-09

ALPHA 4 BETA 7 INTEGRIN MODULATORS AND USES THEREOF

#22
20250268906
2025-08-28

MOLECULAR GLUE COMPOUND BASED ON CEREBLON PROTEIN DESIGN AND USE THEREOF

#23
20250250230
2025-08-07

HETEROCYCLIC COMPOUND

#24
20250236593
2025-07-24

SMALL MOLECULES THAT SENSITIZE HIV-1 INFECTED CELLS TO ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY

#25
20250228865
2025-07-17

COMPOUNDS FOR ENHANCING READ THROUGH OF GENES CONTAINING PREMATURE TERMINATION CODONS AND METHODS FOR MAKING AND USING THE SAME

#26
20250213558
2025-07-03

T-TYPE CALCIUM CHANNEL MODULATORS COMPRISING A PIPERAZINE OR 1,4-DIAZEPANE CORE AND METHODS OF USE THEREOF

#27
20250179036
2025-06-05

MORPHOLINE-3-CARBOXAMIDE DERIVATIVES AS PROSTAGLANDIN E2 RECEPTOR 4 (EP4) AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL AND PULMONARY DISEASES

#28
20250163372
2025-05-22

METHOD OF INHIBITING TAU PHOSPHORYLATION

#29
20250162988
2025-05-22

CRYSTALS OF VITAMIN D DERIVATIVE OR CRYSTALS OF SOLVATE THEREOF

#30
20250154181
2025-05-15

TREPROSTINIL PRODRUGS

#31
20250154109
2025-05-15

SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE

#32
20250122216
2025-04-17

Compounds for the Treatment of Cancer and Inflammatory Disease

#33
20250122180
2025-04-17

DERIVATIVES OF SUBSTITUTED MORPHOLINES AND USES THEREOF

#34
20250100981
2025-03-27

Cis-substituted 5-(hydroxymethyl)morpholine-2-carboxamides as agonists of SSTR4

#35
20250092361
2025-03-20

METHOD OF INHIBITING TAU PHOSPHORYLATION

#36
20250066313
2025-02-27

Methods of Synthesis of Chiral 3,5-Disubstituted Morpholine Compounds and Intermediates Useful Therein

#37
20250066290
2025-02-27

DHODH INHIBITORS CONTAINING A CARBOXYLIC ACID BIOISOSTERE

#38
20250051316
2025-02-13

2-(ARYL-2-YL) MORPHOLINE AND DEUTERATED DERIVATIVE THEREOF, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#39
20250008959
2025-01-09

HERBICIDES AND USE THEREOF

#40
20250002450
2025-01-02

CATIONIC STEROID COMPOUNDS, METHOD OF OBTAINING THEREOF, FORMULATIONS COMPRISING THEREOF AND THEIR USES

#41
20240425447
2024-12-26

BENZOYLGLYCINE DERIVATIVES AND METHODS OF MAKING AND USING SAME

#42
20240417378
2024-12-19

G-PROTEIN-COUPLED RECEPTOR REGULATORS AND METHODS OF USE THEREOF

#43
20240415851
2024-12-19

REMODILINS TO PREVENT OR TREAT CANCER METASTASIS, GLAUCOMA, AND HYPOXIA

#44
20240409509
2024-12-12

COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES

#45
20240391938
2024-11-28

CRYSTALLINE FORMS OF A TLR7/TLR8 INHIBITOR

#46
20240391884
2024-11-28

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

#47
20240391883
2024-11-28

HETEROCYCLIC COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE

#48
20240368077
2024-11-07

NOVEL POTASSIUM CHANNEL INHIBITORS

#49
20240366614
2024-11-07

ARYLQUINAZOLINES

#50
20240360114
2024-10-31

FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF

#51
20240351992
2024-10-24

PREPARATION OF P2X3 ANTAGONIST

#52
20240343699
2024-10-17

DERIVATIVES OF SUBSTITUTED MORPHOLINES AND USES THEREOF

#53
20240336581
2024-10-10

DERIVATIVES OF SUBSTITUTED MORPHOLINES AND USES THEREOF

#54
20240317727
2024-09-26

COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER

#55
20240316038
2024-09-26

APOL1 INHIBITORS AND METHODS OF USE

#56
20240300907
2024-09-12

MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS

#57
20240294467
2024-09-05

USP9X inhibitors

#58
20240287018
2024-08-29

TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME

#59
20240270705
2024-08-15

COMPOUNDS SELECTIVE FOR JAK1 AND METHODS OF USE

#60
20240254083
2024-08-01

HETEROCYCLIC TRPML1 AGONISTS AND USES THEREOF

#61
20240226287
2024-07-11

NOVEL LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION COMPRISING THE SAME

#62
20240226114
2024-07-11

INHIBITORS AND USES THEREOF

#63
20240217922
2024-07-04

MODULATORS OF SORTILIN ACTIVITY

#64
20240208916
2024-06-27

AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME

#65
20240199535
2024-06-20

DEUTERATED DHODH INHIBITORS

#66
20240182486
2024-06-06

P38ALPHA MITOGEN-ACTIVATED PROTEIN KINASE INHIBITORS

#67
20240182458
2024-06-06

Derivatives of substituted morpholines and uses thereof

#68
20240166612
2024-05-23

ARYLTHIOETHER ACETAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS

#69
20240132450
2024-04-25

MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88

#70
20240117306
2024-04-11

METHOD OF INHIBITING TAU PHOSPHORYLATION

#71
20240116884
2024-04-11

Salts of Viloxazine

#72
20240116883
2024-04-11

CANNABINOID DERIVATIVES AND THEIR USE THE TREATMENT OF INFLAMMATION AND/OR PAIN AND/OR OBESITY

#73
20240093089
2024-03-21

COMPOSITION AND PROCESS FOR SELECTIVELY ETCHING A LAYER COMPRISING AN ALUMINIUM COMPOUND IN THE PRESENCE OF LAYERS OF LOW-K MATERIALS, COPPER AND/OR COBALT

#74
20240092743
2024-03-21

METHODS OF MAKING DELMOPINOL AND SALTS THEREOF

#75
20240051979
2024-02-15

Treprostinil prodrugs

#76
20240043439
2024-02-08

COMPOUNDS AS C5AR INHIBITORS

#77
20240043395
2024-02-08

COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING

#78
20240018132
2024-01-18

5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER

#79
20240009153
2024-01-11

BUMETANIDE ANALOGS, COMPOSITIONS AND METHODS OF USE

#80
20230416210
2023-12-28

METHODS OF MAKING A PPAR-DELTA AGONIST

#81
20230399297
2023-12-14

Novel Glutamine Analogs

#82
20230382875
2023-11-30

COMPOUNDS, COMPOSITIONS, AND METHODS FOR ISOLATION OF NUCLEIC ACIDS

#83
20230357208
2023-11-09

MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS

#84
20230357173
2023-11-09

Process of making derivatives of substituted morpholines

#85
20230357172
2023-11-09

Perfluorinated Allyl Ethers and Perfluorinated Allyl Amines and Methods of Making and Using the Same

#86
20230348376
2023-11-02

VITAMIN D DERIVATIVE HAVING CYCLIC AMINE IN SIDE CHAIN

#87
20230339851
2023-10-26

CXCR6 SULFONAMIDE COMPOUNDS

#88
20230331691
2023-10-19

Treprostinil derivative compounds and methods of using same

#89
20230331675
2023-10-19

AROMATIC ETHYLENE COMPOUND AND PREPARATION METHOD THEREFOR, AND INTERMEDIATE, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF

#90
20230295100
2023-09-21

PROCESS OF MAKING DERIVATIVES OF SUBSTITUTED MORPHOLINES

#91
20230286997
2023-09-14

Compounds for the treatment of cancer and inflammatory disease

#92
20230250061
2023-08-10

Functionalized ionic liquid for solvating heavy aromatic compounds

#93
20230250042
2023-08-10

CURCUSONE DITERPENOIDS AND USES THEREOF

#94
20230192611
2023-06-22

MODULATORS OF HEMOGLOBIN

#95
20230174484
2023-06-08

ANTAGONISTS OF GPR39 PROTEIN

#96
20230159507
2023-05-25

MODULATORS OF HEMOGLOBIN

#97
20230159474
2023-05-25

Modulators of Mas-related G-protein receptor X4 and related products and methods

#98
20230159446
2023-05-25

Methods and Compositions for Targeting Tregs using CCR8 Inhibitors

#99
20230159441
2023-05-25

ENZYME-CLEAVABLE METHADONE PRODRUGS AND METHODS OF USE THEREOF

#100
20230150924
2023-05-18

NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND

#101
20230146127
2023-05-11

3-DIARYLMETHYLENES AND USES THEREOF

#102
20230142739
2023-05-11

PROTEIN-PROTEIN INTERACTION STABILIZERS

#103
20230134821
2023-05-04

Myc-Max inhibitor compound therapeutics for cancer treatment, methods and uses associated therewith

#104
20230131535
2023-04-27

ARYLMETHYLENE AROMATIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS

#105
20230130822
2023-04-27

LOW TOXICITY NMP SUBSTITUTES AND USES THEREOF

#106
20230103444
2023-04-06

SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER

#107
20230101612
2023-03-30

PREPARATION OF A P2X3 ANTAGONIST

#108
20230098847
2023-03-30

QUATERNARY HETEROATOM CONTAINING COMPOUNDS

#109
20230096766
2023-03-30

AMINO ACID HAVING FUNCTIONAL GROUP CAPABLE OF INTERMOLECULAR HYDROGEN BONDING, PEPTIDE COMPOUND CONTAINING SAME AND METHOD FOR PRODUCTION THEREOF

#110
20230094524
2023-03-30

Methods of making delmopinol and salts thereof

#111
20230090562
2023-03-23

P38α mitogen-activated protein kinase inhibitors

#112
20230089459
2023-03-23

Chemical compounds targeting the eye and use thereof in the treatment of eye diseases

#113
20230079631
2023-03-16

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

#114
20230053860
2023-02-23

Modulators of mas-related G-protein receptor X4 and related products and methods

#115
20230038589
2023-02-09

Methods and compositions for targeting Tregs using CCR8 inhibitors

#116
20230010299
2023-01-12

HETEROCYCLIC TRPML1 AGONISTS

#117
20220402841
2022-12-22

Stilbene derivative and method for preparing same

#118
20220388947
2022-12-08

Nitrogen-containing Derivative of Substituted Phenol Hydroxy Acid Ester, and Preparation and Use Thereof

#119
20220387926
2022-12-08

COMPOSITIONS AND METHODS FOR CARBON DIOXIDE CAPTURE

#120
20220380314
2022-12-01

SUBSTITUTED, SATURATED AND UNSATURATED N-HETEROCYCLIC CARBOXAMIDES AND RELATED COMPOUNDS FOR THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS

#121
20220380298
2022-12-01

Inhibitors of the n-terminal domain of the androgen receptor

#122
20220363639
2022-11-17

Small molecules that sensitize HIV-1 infected cells to antibody dependent cellular cytotoxicity

#123
20220356153
2022-11-10

Compositions for treating neurodegenerative diseases

#124
20220348544
2022-11-03

Ketamine compounds and processes for making and using them

#125
20220332725
2022-10-20

Compounds for the treatment of cancer and inflammatory disease

#126
20220306618
2022-09-29

Derivatives of substituted morpholines and uses thereof

#127
20220298155
2022-09-22

COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING

#128
20220298150
2022-09-22

Derivatives of substituted morpholines and uses thereof

#129
20220289673
2022-09-15

WDR5-MYC INHIBITORS

#130
20220281804
2022-09-08

Cyclic diones as herbicidal compounds

#131
20220267283
2022-08-25

HETEROCYCLIC COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE

#132
20220267269
2022-08-25

COMPOUNDS FOR THE MODULATION OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9)

#133
20220267263
2022-08-25

CARBAMATE-SUBSTITUTED STYRYL SULFONE COMPOUNDS, PREPARATION METHOD AND USE THEREOF

#134
20220227792
2022-07-21

CARBORANE HYDROXAMIC ACID MATRIX METALLOPROTEINASE AGENTS FOR BORON NEUTRON CAPTURE THERAPY

#135
20220194928
2022-06-23

NOVEL N-ACYLUREA DERIVATIVE AND COMPOSITION COMPRISING SAME FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASE

#136
20220185806
2022-06-16

INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 30

#137
20220169602
2022-06-02

Potassium channel inhibitors

#138
20220162224
2022-05-26

p38α mitogen-activated protein kinase inhibitors

#139
20220162197
2022-05-26

MYST family histone acetyltransferase inhibitors

#140
20220117970
2022-04-21

ARYLQUINAZOLINES

#141
20220112173
2022-04-14

Treprostinil derivative compounds and methods of using same

#142
20220112157
2022-04-14

MYC-MAX INHIBITOR COMPOUND THERAPEUTICS FOR CANCER TREATMENT, METHODS AND USES ASSOCIATED THEREWITH

#143
20220071935
2022-03-10

BUMETANIDE ANALOGS, COMPOSITIONS AND METHODS OF USE

#144
20220048849
2022-02-17

Decarboxylase inhibitors for treating Parkinson's disease

#145
20220041641
2022-02-10

QUATERNARY AMMONIUM SALTS AS INHIBITORS OF TRIMETHYLAMINE PRODUCTION

#146
20220040207
2022-02-10

REMODILINS TO PREVENT OR TREAT CANCER METASTASIS, GLAUCOMA, AND HYPOXIA

#147
20220024885
2022-01-27

METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOF

#148
20220024884
2022-01-27

Compounds and methods for inhibiting viral replication and methods of treating and preventing flaviviral infections

#149
20210395189
2021-12-23

SUBSTITUTED TETRACYCLINE COMPOUNDS

#150
20210371390
2021-12-02

Amyloid targeting agents and methods of using the same

#151
20210363098
2021-11-25

Diversity-oriented synthesis of N,N,O-trisubstituted hydroxylamines from alcohols and amines by N—O bond formation

#152
20210355135
2021-11-18

P38α mitogen-activated protein kinase inhibitors

#153
20210315895
2021-10-14

Benzathine analogs

#154
20210302113
2021-09-30

FLUORINATED DIAMINOOLEFINS AND METHODS OF USING THE SAME

#155
20210284631
2021-09-16

Cyano-substituted heterocycles with activity as inhibitors of USP30

#156
20210230129
2021-07-29

Compounds and compositions for treating conditions associated with NLRP activity

#157
20210230112
2021-07-29

NANOMATERIALS

#158
20210221776
2021-07-22

Perfluoroaminoolefins and methods of making and using the same

#159
20210214322
2021-07-15

Compounds useful in the treatment of disorders associated with mutant RAS

#160
20210206783
2021-07-08

Crystalline forms of a TLR7/TLR8 inhibitor

#161
20210206715
2021-07-08

Benzoylglycine derivatives and methods of making and using same

#162
20210198384
2021-07-01

METHOD FOR PREPARING CELLULOSE DOPE

#163
20210188758
2021-06-24

Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

#164
20210188753
2021-06-24

HIF-1α inhibitor, preparation method therefor, and pharmaceutical composition for preventing or treating angiogenesis-associated eye disease, containing same as active ingredient

#165
20210179542
2021-06-17

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

#166
20210171439
2021-06-10

Hepatitis B capsid assembly modulators

#167
20210155592
2021-05-27

Quaternary heteroatom containing compounds

#168
20210147499
2021-05-20

Conjugates for delivering an anti-cancer agent to nerve cells, methods of use and methods of making thereof

#169
20210139897
2021-05-13

OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS

#170
20210130307
2021-05-06

Method for the manufacturing of delmopinol intermediates

#171
20210095248
2021-04-01

Method of inhibiting tau phosphorylation

#172
20210093618
2021-04-01

SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF

#173
20210078947
2021-03-18

Therapeutic compounds and methods of use thereof

#174
20210078936
2021-03-18

Lipids and lipid compositions for the delivery of active agents

#175
20210072254
2021-03-11

Reagents and methods for analysis of proteins and metabolites targeted by covalent probes

#176
20210061760
2021-03-04

Substituted benzamides

#177
20210054009
2021-02-25

Treprostinil prodrugs

#178
20210047309
2021-02-18

Modulators of hemoglobin

#179
20210040052
2021-02-11

Probucol derivative, preparation method therefor and use thereof

#180
20210040051
2021-02-11

Salt of delmopinol

#181
20210032213
2021-02-04

MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS

#182
20210008022
2021-01-14

Hydroquinone compounds, preparation methods therefor, and use in anti-tumor or immunomodulation therapy

#183
20200407364
2020-12-31

FUSED BICYCLIC COMPOUNDS

#184
20200407336
2020-12-31

Treprostinil derivative compounds and methods of using same

#185
20200339523
2020-10-29

COMPOSITION AND PROCESS FOR SELECTIVELY ETCHING A LAYER COMPRISING AN ALUMINIUM COMPOUND IN THE PRESENCE OF LAYERS OF LOW-K MATERIALS, COPPER AND/OR COBALT

#186
20200331882
2020-10-22

COMPOUND FOR SIMULTANEOUSLY INHIBITING LSD1 AND HDAC TARGETS AND APPLICATION THEREOF

#187
20200325106
2020-10-15

Heterocyclic compounds for cancer imaging and treatment and methods for their use

#188
20200317658
2020-10-08

Inhibiting ubiquitin specific peptidase 30

#189
20200317626
2020-10-08

Autotaxin inhibitors

#190
20200308163
2020-10-01

Compounds and compositions as modulators of TLR signaling

#191
20200299419
2020-09-24

Modification polymerization initiator and method for preparing the same

#192
20200299234
2020-09-24

Compositions for treating neurodegenerative diseases

#193
20200270220
2020-08-27

Ascochlorin derivative and use thereof as AMPK activator

#194
20200231537
2020-07-23

Reductive alkylation of amines with orthocarboxylic acid esters

#195
20200223845
2020-07-16

Viral replication inhibitors

#196
20200215073
2020-07-09

Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

#197
20200190066
2020-06-18

Compound used as autophagy regulator, and preparation method therefor and uses thereof

#198
20200182617
2020-06-11

Necrosis inhibitors

#199
20200181115
2020-06-11

Method for preparing 2-hydroxyl-4-(2, 3-disubstituted benzyloxy)-5-substituted benzaldehyde derivative

#200
20200165214
2020-05-28

Albicidin derivatives, their use and synthesis

#201
20200165213
2020-05-28

Substituted 2,3-dihydro-1H-indene analogs and methods using same

#202
20200157063
2020-05-21

Method for preparation of alkylated or fluoro, chloro and fluorochloro alkylated compounds by heterogeneous cobalt catalysis

#203
20200157049
2020-05-21

Quaternary heteroatom containing compounds

#204
20200157048
2020-05-21

(2E,4E)-5-PHENYL-PENTA-2,4-DIEN-1-ONE DERIVATIVE

#205
20200148668
2020-05-14

Decarboxylative cross-coupling and applications thereof

#206
20200148635
2020-05-14

FORMIMIDAMIDINE COMPOUNDS USEFUL AGAINST PHYTOPATHOGENIC MICROORGANISMS

#207
20200140382
2020-05-07

Substituted sulfoximine compounds

#208
20200140376
2020-05-07

Resorcinol derivatives for their cosmetic use

#209
20200123118
2020-04-23

Amyloid targeting agents and methods of using the same

#210
20200115360
2020-04-16

Enzyme-triggered carbon monoxide releasing molecules

#211
20200115339
2020-04-16

EFFLUX-PUMP INHIBITORS AND THERAPEUTIC USES THEREOF

#212
20200113900
2020-04-16

Benzathine analogs

#213
20200108054
2020-04-09

SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF

#214
20200079732
2020-03-12

Compounds and uses thereof for the modulation of hemoglobin

#215
20200069690
2020-03-05

Arylquinazolines

#216
20200062726
2020-02-27

Treprostinil derivative compounds and methods of using same

#217
20200062703
2020-02-27

Compounds, compositions, methods for treating diseases, and methods for preparing compounds

#218
20200055819
2020-02-20

Nicotinyl alcohol ether derivative, preparation method therefor, and pharmaceutical composition and uses thereof

#219
20200048194
2020-02-13

SUBSTITUTED BENZAMIDES

#220
20200048186
2020-02-13

Process for productions of formamides and acrylamides

#221
20200040160
2020-02-06

PVC plasticizers and methods for making thereof

#222
20200031790
2020-01-30

Simple oxidative functionalized of alkyl aryl ketones

#223
20200024226
2020-01-23

Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same

#224
20200002544
2020-01-02

Fluorenylaminoketone photoinitiator, preparation method thereof, and UV photocurable composition containing same

#225
20190382338
2019-12-19

4-substituted phenylamine derivatives and their use to protect crops by fighting undesired phytopathogenic micoorganisms

#226
20190382335
2019-12-19

Inhibitors of the N-terminal domain of the androgen receptor

#227
20190375722
2019-12-12

Method for the manufacturing of delmopinol

#228
20190367446
2019-12-05

Benzoylglycine derivatives and methods of making and using same

#229
20190367445
2019-12-05

4-AMINO SUBSTITUTED PHENYLAMIDINE DERIVATIVES AND THEIR USE TO PROTECT CROPS BY FIGHTING UNDESIRED PHYTOPATHOGENIC MICOORGANISMS

#230
20190346454
2019-11-14

Reagents and methods for analysis of proteins and metabolites targeted by covalent probes

#231
20190337906
2019-11-07

Urea compound and preparation method and application thereof

#232
20190329176
2019-10-31

Compositions and methods for carbon dioxide capture

#233
20190300492
2019-10-03

METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOF

#234
20190300477
2019-10-03

Compounds and uses thereof for the modulation of hemoglobin

#235
20190292163
2019-09-26

Treprostinil derivative compounds and methods of using same

#236
20190284226
2019-09-19

Thionyl tetrafluoride modified compounds and uses

#237
20190270699
2019-09-05

4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

#238
20190263775
2019-08-29

Glucosylceramide synthase inhibitors for the treatment of diseases

#239
20190256506
2019-08-22

Salts of quinazoline derivative or crystals thereof, and the process for producing thereof

#240
20190255009
2019-08-22

Stilbene derivative and method for preparing same

#241
20190248729
2019-08-15

Stilbene derivative and method for preparing same

#242
20190241531
2019-08-08

Benzyl phenyl ether derivative, preparation method therefor, and pharmaceutical composition and uses thereof

#243
20190233405
2019-08-01

Phenylate derivative, preparation method therefor, and pharmaceutical composition and uses thereof

#244
20190218551
2019-07-18

Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

#245
20190218229
2019-07-18

Compounds for the treatment of cancer and inflammatory disease

#246
20190202801
2019-07-04

Piperazine carbamates and methods of making and using same

#247
20190202782
2019-07-04

Compounds and uses thereof for the modulation of hemoglobin

#248
20190194163
2019-06-27

Dual NAV1.2/5HT2a inhibitors for treating CNS disorders

#249
20190185438
2019-06-20

SALTS AND POLYMORPHS OF ESREBOXETINE

#250
20190177288
2019-06-13

Intermediates and process for preparing intermediates in the production of substituted pyrazolopyridines

#251
20190177287
2019-06-13

Hydrates of substituted 5-fluoro-1H-pyrazolopyridines

#252
20190175607
2019-06-13

Method of maintaining oral health in animals

#253
20190151263
2019-05-23

BUMETANIDE ANALGOS, COMPOSITIONS, AND METHODS OF USE

#254
20190142833
2019-05-16

Arylquinazolines

#255
20190136184
2019-05-09

Method of inhibiting tau phosphorylation

#256
20190135733
2019-05-09

Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof

#257
20190119261
2019-04-25

N-acylurea derivative and composition comprising same for prevention or treatment of cardiovascular disease

#258
20190119241
2019-04-25

Compounds and compositions for treating conditions associated with NLRP activity

#259
20190100507
2019-04-04

Fluorinated cyclopropylamine compound, preparation method therefor, pharmaceutical composition thereof, and uses thereof

#260
20190091222
2019-03-28

Benzathine analogs

#261
20190084993
2019-03-21

Pharmacologically active compounds

#262
20190071395
2019-03-07

Compound having BLT inhibitory activity and composition, for preventing or treating inflammatory diseases, comprising same as active ingredient

#263
20190040028
2019-02-07

ARYLATION OF ALIPHATIC AMINES

#264
20190040027
2019-02-07

Synthesis of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine

#265
20190040024
2019-02-07

Amine-containing acyclic hydrofluoroethers and methods of using the same

#266
20190038578
2019-02-07

Necrosis inhibitors

#267
20190031607
2019-01-31

Therapeutic compounds and methods of use thereof

#268
20190022049
2019-01-24

Hydroquinone compounds, preparation methods therefor, and use in anti-tumor or immunomodulation therapy

#269
20190010121
2019-01-10

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOBLOGIN

#270
20180362481
2018-12-20

Amide compound, methods for preparation, and use thereof as agent for the treatment and prevention of diseases caused by rna- and/or dna-containing viruses, and concomitant diseases

#271
20180346473
2018-12-06

FUSED BICYCLIC COMPOUNDS

#272
20180339971
2018-11-29

Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonists

#273
20180339968
2018-11-29

Quaternary heteroatom containing compounds

#274
20180327373
2018-11-15

Amyloid targeting agents and methods of using the same

#275
20180327368
2018-11-15

Heterocyclic compounds for cancer imaging and treatment and methods for their use

#276
20180312478
2018-11-01

Allylic terminally unsaturated hydrofluoroamine and allylic terminally unsaturated hydrofluoroether compounds and methods of using the same

#277
20180298262
2018-10-18

Hydrofluoroether olefins and methods of using same

#278
20180290965
2018-10-11

Lipids and lipid compositions for the delivery of active agents

#279
20180265482
2018-09-20

Methods for producing viloxazine salts and novel polymorphs thereof

#280
20180244606
2018-08-30

Farnesoid X receptor agonists and uses thereof

#281
20180222856
2018-08-09

Selective inhibitors of carbonic anhydrase

#282
20180215744
2018-08-02

Salts of quinazoline derivative or crystals thereof, and the process for producing thereof

#283
20180215706
2018-08-02

Compound having BLT inhibitory activity and composition, for preventing or treating inflammatory diseases, comprising same as active ingredient

#284
20180208576
2018-07-26

Selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors

#285
20180201577
2018-07-19

Compounds and uses thereof for the modulation of hemoglobin

#286
20180201573
2018-07-19

Compound having BLT inhibitory activity and composition, for preventing or treating inflammatory diseases, comprising same as active ingredient

#287
20180194718
2018-07-12

Neprilysin inhibitors

#288
20180186725
2018-07-05

Method for the homogeneous catalytic reductive amination of carbonyl compounds

#289
20180179169
2018-06-28

Phenyl amino pyrimidine compound or polymorph of salt thereof

#290
20180179158
2018-06-28

Efflux-pump inhibitors and therapeutic uses thereof

#291
20180162829
2018-06-14

Treprostinil derivative compounds and methods of using same

#292
20180162807
2018-06-14

Aromatic compounds and uses thereof

#293
20180148455
2018-05-31

Method of treating Crohn's disease comprising a TLR2 antagonist

#294
20180141893
2018-05-24

Hydrofluoroolefins and methods of using same

#295
20180141887
2018-05-24

Hydrofluoroolefins and methods of using same

#296
20180118657
2018-05-03

METHODS FOR INHIBITING MUSCLE ATROPHY

#297
20180111894
2018-04-26

Benzimidazole inhibitors of the sodium channel

#298
20180086730
2018-03-29

Treprostinil derivative compounds and methods of using same

#299
20180079712
2018-03-22

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer

#300
20180072660
2018-03-15

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer